FDA is ordering manufacturers of transvaginal surgical mesh and mini-slings to conduct post-market studies to assess safety complications with the devices used to repair women’s pelvic problems.
On Jan. 3, FDA sent 88 post-market study orders to 33 manufacturers of urogynecologic surgical mesh used for pelvic organ prolapse